Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Mouse CDKN2A/p16INK4a Protein, N-His

Catalog #:   YME37701 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P51480
Protein length: Met1-Ser135
Overview

Catalog No.

YME37701

Expression system

E. coli

Species

Mus musculus (Mouse)

Protein length

Met1-Ser135

Predicted molecular weight

16.64 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P51480

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Cyclin-dependent kinase inhibitor 2A, Cyclin-dependent kinase 4 inhibitor A, CDK4I, p16-INK4a, p16-INK4, Cdkn2a, P16ink4a

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Mouse CDKN2A/p16INK4a protein
References

Spatial Distribution and Prognostic Value of T Cell Subtypes and Immune Biomarkers in p16-Negative HNSCC., PMID:40497965

[Combined detection of p16 and Rb with high-risk human papilloma virus infection in non-oropharyngeal squamous cell carcinoma of the head and neck]., PMID:40494765

Premature cell senescence promotes vascular smooth muscle cell phenotypic modulation and resistance to re-differentiation., PMID:40493738

Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms., PMID:40474207

Fibroblasts-specific p16INK4a exacerbates inflammageing-mediated post-infarction ventricular remodelling through interacting with STAT3 to regulate NLRP3 transcription., PMID:40462499

[Mechanism of matrine against senescence in human umbilical vein endothelial cells based on network pharmacology and experimental verification]., PMID:40461235

Cuproptosis-related gene signatures define the immune microenvironment in diabetic nephropathy., PMID:40460381

Evidence of mutations in tumour suppressor genes among oral cancer in Naswar, smokeless tobacco users., PMID:40457841

A comparison of CDKN2A status in gliomas using different techniques: The loss of p16 as a surrogate marker., PMID:40445894

Detection of hotspot mutations in oral cancer through Ion AmpliSeq™ cancer hotspot panel v.2.0: A circulating DNA fragmentomics approach in the Northeast Indian population., PMID:40440828

Role of the SPI1/CDKN2A/p53 signaling pathway in cuproptosis of lung adenocarcinoma cells., PMID:40438868

Polygenic Risk Score Analysis of 37 SNPs Associated with Melanoma Risk in Colombian Population., PMID:40429816

Pancreatic adenocarcinoma in a patient with a germline RB1 pathogenic variant., PMID:40418431

Myocardial infarction activates the 9p21.3 orthologous locus expression, but its absence does not alter cardiac pathophysiology in ischemia., PMID:40405527

Repurposing HIV protease inhibitors as senotherapeutic agents in cervical cancer: Dual targeting of CDK1/6-cell cycle arrest and p53/p21/p16 signaling axis., PMID:40403681

Palbociclib, a Selective CDK4/6 Inhibitor, Administered Before and After Chemoradiotherapy for Human Papillomavirus-Negative, Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm, Phase II Trial., PMID:40403207

Development of a highly sensitive, label-free electrochemical immunosensor for p16INK4a detection: a step toward early cervical cancer diagnosis., PMID:40396400

Improving Detection of CIN2+ and CIN3+ Lesions: Evaluation of E6/E7 mRNA, P16, and Ki-67, Individually and in Combination., PMID:40392038

Atf3 + senescent chondrocytes mediate meniscus degeneration in aging., PMID:40375324

Role of genomic analysis in the classification of well differentiated hepatocellular lesions., PMID:40374146

Diagnostic Accuracy of Serum P16ink4A and FOX-P3 Concentrations for Detection of Cervical Lesions Among Women Attending a Cervical Cancer Clinic in Western Uganda: A Case-Control Study., PMID:40365511

Radiation-Induced Synchronous Parathyroid Carcinoma and Papillary Thyroid Carcinoma: Clinical, Morphological, and Genetic Insights., PMID:40362680

Molecular Mechanisms of Tumor Progression and Novel Therapeutic and Diagnostic Strategies in Mesothelioma., PMID:40362535

Radiation-Induced Meningiomas Have an Aggressive Clinical Course: Genetic Signature Is Limited to NF2 Alterations, and Epigenetic Signature Is H3K27me3 Loss., PMID:40359980

P16 hypermethylation is a potential cause of oxidative stress due to long-term exposure to hexavalent chromium., PMID:40358560

A Dominant Mutation in Gαs-Protein Increases Hair Pigmentation., PMID:40356280

Elevated Type I Interferon Signaling Defines the Proliferative Advantage of ARF and p53 Mutant Tumor Cells., PMID:40351125

Basal-shift transformation leads to EGFR therapy-resistance in human lung adenocarcinoma., PMID:40350470

Plasmacytoid urothelial carcinoma of the urinary bladder: A single institution experience with focus on next-generation sequencing (NGS) and PD-L1 immunohistochemistry., PMID:40349989

Cellular senescence promotes macrophage-to-myofibroblast transition in chronic ischemic renal disease., PMID:40348745

Identification of programmed cell death-related genes and construction of a prognostic model in oral squamous cell carcinoma using single-cell and transcriptome analysis., PMID:40346375

Clinical characteristics and treatment outcome in p16 negative anal cancer., PMID:40336180

Downregulation of EZH2 Promotes Renal Epithelial Cellular Senescence and Kidney Aging., PMID:40326780

[Prognostic Value of CDKN2A Copy Number Deletion in Patients with Diffuse Large B-Cell Lymphoma]., PMID:40326108

Unlocking the power of immune checkpoint inhibitors: Targeting YAP1 reduces anti-PD1 resistance in skin cutaneous melanoma., PMID:40324810

Establishment and validation of a novel risk model based on PANoptosis-related genes to predict prognosis in head and neck squamous cell carcinoma., PMID:40324259

Preoperative prediction of p16 expression in cervical cancer by amide proton transfer imaging combined with diffusion kurtosis imaging: a retrospective study., PMID:40321828

Quercetin ameliorates ox-LDL-induced cellular senescence of aortic endothelial cells and macrophages by p16/p21, p53/SERPINE1, and AMPK/mTOR pathways., PMID:40319296

Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A., PMID:40317086

A model workflow for microfluidic enrichment and genetic analysis of circulating melanoma cells., PMID:40316673

Diagnostic Utility of Preferentially Expressed Antigen in Melanoma (PRAME) and p16 Immunohistochemistry in Distinguishing Genital Melanomas From Benign Melanocytic Proliferations., PMID:40314660

A novel immortalization method for immortalizing human primary CD8+ T cells by inserting a single copy of human telomerase reverse transcriptase via CRISPR/Cas9., PMID:40311322

Genetic alterations of Cyclin D-CDK4/6-INK4-RB pathway in prostate cancer., PMID:40304827

Lower levels of senescence in human lung mesenchymal stromal cells compared with lung fibroblasts: implications for tissue regeneration in COPD., PMID:40304287

Molecular characteristics and responses to EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients with EGFR exon 19 insertions., PMID:40301895

TGFBR2 as a prognostic marker and therapeutic target in benzo(a)pyrene-associated esophageal cancer: insights from multi-omics analysis., PMID:40293202

Treatment outcomes of BTK inhibitors and venetoclax with or without anti-CD20 monoclonal antibody in relapsed or refractory mantle cell lymphoma., PMID:40278919

Accelerated senescence of bone marrow erythrocyte precursors in myelodysplastic syndrome., PMID:40277030

Loss of ALDH2 accelerates the progression of pulmonary arterial hypertension through the 4-HNE/ERK1/2-p16INK4a signaling pathway., PMID:40274079

Human papillomavirus (HPV) related oropharyngeal cancers in Canada: A multicenter retrospective cohort study., PMID:40264440

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Mouse CDKN2A/p16INK4a Protein, N-His [YME37701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only